TILCX
Price
$24.98
Change
-$0.26 (-1.03%)
Updated
Sep 6 closing price
VVIAX
Price
$65.30
Change
-$0.84 (-1.27%)
Updated
Sep 6 closing price
Ad is loading...

TILCX vs VVIAX

Header iconTILCX vs VVIAX Comparison
Open Charts TILCX vs VVIAXBanner chart's image
T. Rowe Price Lrg Cp Va I
Price$24.98
Change-$0.26 (-1.03%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index Adm
Price$65.30
Change-$0.84 (-1.27%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
TILCX vs VVIAX Comparison Chart
Loading...
VS
TILCX vs. VVIAX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TILCX is a Buy and VVIAX is a Buy.

FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 183B vs. TILCX (3.54B). VVIAX pays higher dividends than TILCX: VVIAX (2.36) vs TILCX (2.01). TILCX was incepted earlier than VVIAX: TILCX (24 years) vs VVIAX (24 years). TILCX is a more actively managed with annual turnover of: 28.20 vs. VVIAX (10.00). VVIAX has a lower initial minimum investment than TILCX: VVIAX (3000) vs TILCX (500000). VVIAX annual gain was more profitable for investors over the last year : 19.30 vs. TILCX (15.15). VVIAX return over 5 years is better than : 53.51 vs. TILCX (19.06).
TILCXVVIAXTILCX / VVIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years24 years-
Gain YTD12.47813.50692%
Front LoadN/AN/A-
Min. Initial Investment500000300016,667%
Min. Initial Investment IRAN/AN/A-
Net Assets3.54B183B2%
Annual Yield % from dividends2.012.3685%
Returns for 1 year15.1519.3079%
Returns for 3 years-6.5119.68-33%
Returns for 5 years19.0653.5136%
Returns for 10 years40.44107.5738%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GDYN14.080.47
+3.45%
Grid Dynamics Holdings
USEG0.910.01
+1.00%
US Energy Corp
BCE35.950.07
+0.20%
BCE
LNKB6.15N/A
N/A
LINKBANCORP
CRNX50.98-1.82
-3.45%
Crinetics Pharmaceuticals